“The extension of time granted is without prejudice to Bursa’ right to proceed to suspend the trading of Pharmaniaga’s listed securities and to delist the company in the event it fails to implement its regularisation plan within the time frame or extended time frame stipulated by any of the regulatory authorities,” the company said in a filing with Bursa.

Pharmaniaga said if it fails to carry out the regularisation plan within the given time frame, Bursa will serve the company with a suspension notification before suspending trading of listed securities on the sixth market date from the suspension.

Pharmaniaga will then be delisted, subject to the company’s right to appeal against the delisting, it said.